Rydén AK - Search Results

1

Oral insulin (human, murine, or porcine) does not prevent diabetes in the non-obese diabetic mouse.

Pham MN, Gibson C, Rydén AK, Perdue N, Boursalian TE, Pagni PP, Coppieters K, Skonberg C, Porsgaard T, von Herrath M, Vela JL. Pham MN, et al. Among authors: ryden ak. Clin Immunol. 2016 Mar;164:28-33. doi: 10.1016/j.clim.2016.01.013. Epub 2016 Jan 25. Clin Immunol. 2016. PMID: 26821303

2

Anti-IL-21 monoclonal antibody combined with liraglutide effectively reverses established hyperglycemia in mouse models of type 1 diabetes.

Rydén AK, Perdue NR, Pagni PP, Gibson CB, Ratliff SS, Kirk RK, Friesen TJ, Haase C, Coppieters K, von Herrath MG, Boursalian TE. Rydén AK, et al. J Autoimmun. 2017 Nov;84:65-74. doi: 10.1016/j.jaut.2017.07.006. Epub 2017 Jul 12. J Autoimmun. 2017. PMID: 28711285

3

Non-antigenic and antigenic interventions in type 1 diabetes.

Rydén AK, Wesley JD, Coppieters KT, Von Herrath MG. Rydén AK, et al. Hum Vaccin Immunother. 2014;10(4):838-46. doi: 10.4161/hv.26890. Epub 2013 Oct 28. Hum Vaccin Immunother. 2014. PMID: 24165565 Free PMC article. Review.

4

GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients.

Hjorth M, Axelsson S, Rydén A, Faresjö M, Ludvigsson J, Casas R. Hjorth M, et al. Clin Immunol. 2011 Jan;138(1):117-26. doi: 10.1016/j.clim.2010.10.004. Epub 2010 Nov 1. Clin Immunol. 2011. PMID: 21044870 Clinical Trial.

5

General immune dampening is associated with disturbed metabolism at diagnosis of type 1 diabetes.

Rydén A, Ludvigsson J, Fredrikson M, Faresjö M. Rydén A, et al. Pediatr Res. 2014 Jan;75(1-1):45-50. doi: 10.1038/pr.2013.167. Epub 2013 Oct 8. Pediatr Res. 2014. PMID: 24105410

6

Switch from a dominant Th1-associated immune profile during the pre-diabetic phase in favour of a temporary increase of a Th3-associated and inflammatory immune profile at the onset of type 1 diabetes.

Ryden A, Stechova K, Durilova M, Faresjö M. Ryden A, et al. Diabetes Metab Res Rev. 2009 May;25(4):335-43. doi: 10.1002/dmrr.958. Diabetes Metab Res Rev. 2009. PMID: 19382103

7

Altered immune profile from pre-diabetes to manifestation of type 1 diabetes.

Rydén A, Faresjö M. Rydén A, et al. Diabetes Res Clin Pract. 2013 Apr;100(1):74-84. doi: 10.1016/j.diabres.2013.01.014. Epub 2013 Feb 26. Diabetes Res Clin Pract. 2013. PMID: 23485080

8

Efficient expansion of cryopreserved CD4(+)CD25(+)CD127(lo/-) cells in Type 1 diabetes.

Rydén A, Faresjö M. Rydén A, et al. Results Immunol. 2011 Aug 22;1(1):36-44. doi: 10.1016/j.rinim.2011.08.001. eCollection 2011. Results Immunol. 2011. PMID: 24371551 Free PMC article.

9

Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.

Åkesson K, Tompa A, Rydén A, Faresjö M. Åkesson K, et al. Clin Exp Immunol. 2015 Apr;180(1):70-82. doi: 10.1111/cei.12559. Clin Exp Immunol. 2015. PMID: 25421756 Free PMC article. Clinical Trial.

10

Low expression and secretion of circulating soluble CTLA-4 in peripheral blood mononuclear cells and sera from type 1 diabetic children.

Rydén A, Bolmeson C, Jonson CO, Cilio CM, Faresjö M. Rydén A, et al. Diabetes Metab Res Rev. 2012 Jan;28(1):84-96. doi: 10.1002/dmrr.1286. Diabetes Metab Res Rev. 2012. PMID: 22218756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters